Regulation of Ras exchange factors and cellular localization of Ras activation by lipid messengers in T cells

Frontiers in Immunology

Volumn 4, Issue SEP, 2013, Pages

  Jun, Jesse E ^a   Rubio, Ignacio ^b   Roose, Jeroen P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

LAT; Lipids; P38; Ras; RasGRP; Signaling; SOS; T cell

Indexed keywords

EID: 84884886039     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00239     Document Type: Review

References (242)

1. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature (2001) 410:37-40. doi:10.1038/35068583.
2. Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science (2001) 294:1299-304. doi:10.1126/science.1062023.
3. Rajalingam K, Schreck R, Rapp UR, Albert S. Ras oncogenes and their downstream targets. Biochim Biophys Acta (2007) 1773:1177-95. doi:10.1016/j.bbamcr.2007.01.012.
4. Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. Regulating the regulator: post-translational modification of RAS. Nat Rev Mol Cell Biol (2012) 13:39-51. doi:10.1038/nrm3255.
5. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell (2007) 129:865-77. doi:10.1016/j.cell.2007.05.018.
6. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res (1989) 49:4682-9.
7. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol (2008) 9:517-31. doi:10.1038/nrm2438.
8. Vigil D, Cherfils J, Rossman KL, Der CJ. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer (2010) 10:842-57. doi:10.1038/nrc2960.
9. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. Stimulation of p21ras upon T-cell activation. Nature (1990) 346:719-23. doi:10.1038/346719a0.
10. Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA. The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes. J Immunol (1992) 148:2417-22.
11. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Perlmutter RM. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (1995) 373:620-3. doi:10.1038/373620a0.
12. Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, Thomas JF, et al. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J (1995) 14:276-85.
13. Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol (2006) 24:771-800. doi:10.1146/annurev.immunol.24.021605.090723.
14. Yasuda T, Kurosaki T. Regulation of lymphocyte fate by Ras/ERK signals. Cell Cycle (2008) 7:3634-40 doi:10.4161/cc.7.23.7103.
15. Stone JC. Regulation and function of the RasGRP family of Ras activators in blood cells. Genes Cancer (2011) 2:320-34. doi:10.1177/1947601911408082.
16. John J, Rensland H, Schlichting I, Vetter I, Borasio GD, Goody RS, et al. Kinetic and structural analysis of the Mg(2+)-binding site of the guanine nucleotide-binding protein p21H-ras. J Biol Chem (1993) 268:923-9.
17. Cool RH, Schmidt G, Lenzen CU, Prinz H, Vogt D, Wittinghofer A. The Ras mutant D119N is both dominant negative and activated. Mol Cell Biol (1999) 19:6297-305.
18. Dower NA, Stang SL, BottorffDA, Ebinu JO, Dickie P, Ostergaard HL, et al. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol (2000) 1:317-21. doi:10.1038/80799.
19. Ebinu JO, Stang SL, Teixeira C, BottorffDA, Hooton J, Blumberg PM, et al. RasGRP links T-cell receptor signaling to Ras. Blood (2000) 95:3199-203.
20. Kortum RL, Sommers CL, Alexander CP, Pinski JM, Li W, Grinberg A, et al. Targeted Sos1 deletion reveals its critical role in early T-cell development. Proc Natl Acad Sci U S A (2011) 108:12407-12. doi:10.1073/pnas.1104295108.
21. Sondermann H, Soisson SM, Bar-Sagi D, Kuriyan J. Tandem histone folds in the structure of the N-terminal segment of the ras activator Son of Sevenless. Structure (2003) 11:1583-93. doi:10.1016/j.str.2003.10.015.
22. Nimnual AS, Yatsula BA, Bar-Sagi D. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science (1998) 279:560-3. doi:10.1126/science.279.5350.560.
23. Soisson SM, Nimnual AS, Uy M, Bar-Sagi D, Kuriyan J. Crystal structure of the Dbl and pleckstrin homology domains from the human Son of sevenless protein. Cell (1998) 95:259-68. doi:10.1016/S0092-8674(00)81756-0.
24. Lemmon MA. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol (2008) 9:99-111. doi:10.1038/nrm2328.
25. Chen RH, Corbalan-Garcia S, Bar-Sagi D. The role of the PH domain in the signal-dependent membrane targeting of Sos. EMBO J (1997) 16:1351-9. doi:10.1093/emboj/16.6.1351.
26. Koshiba S, Kigawa T, Kim JH, Shirouzu M, Bowtell D, Yokoyama S. The solution structure of the pleckstrin homology domain of mouse Son-of-sevenless 1 (mSos1). J Mol Biol (1997) 269:579-91. doi:10.1006/jmbi.1997.1041.
27. Kubiseski TJ, Chook YM, Parris WE, Rozakis-Adcock M, Pawson T. High affinity binding of the pleckstrin homology domain of mSos1 to phosphatidylinositol (4,5)-bisphosphate. J Biol Chem (1997) 272:1799-804. doi:10.1074/jbc.272.3.1799.
28. Zheng J, Chen RH, Corblan-Garcia S, Cahill SM, Bar-Sagi D, Cowburn D. The solution structure of the pleckstrin homology domain of human SOS1. A possible structural role for the sequential association of diffuse B cell lymphoma and pleckstrin homology domains. J Biol Chem (1997) 272:30340-4. doi:10.1074/jbc.272.48.30340.
29. Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol (2007) 9:706-12. doi:10.1038/ncb1594.
30. Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J. The structural basis of the activation of Ras by Sos. Nature (1998) 394:337-43. doi:10.1038/28548.
31. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M, et al. Structural evidence for feedback activation by Ras. GTP of the Ras-specific nucleotide exchange factor SOS. Cell (2003) 112:685-95. doi:10.1016/S0092-8674(03)00149-1.
32. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (1993) 363:45-51. doi:10.1038/363045a0.
33. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature (1993) 363:85-8. doi:10.1038/363085a0.
34. Innocenti M, Frittoli E, Ponzanelli I, Falck JR, Brachmann SM, Di Fiore PP, et al. Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J Cell Biol (2003) 160:17-23. doi:10.1083/jcb.200206079.
35. Kim MJ, Chang JS, Park SK, Hwang JI, Ryu SH, Suh PG. Direct interaction of SOS1 Ras exchange protein with the SH3 domain of phospholipase C-gamma1. Biochemistry (2000) 39:8674-82. doi:10.1021/bi992558t.
36. Scholler JK, Perez-Villar JJ, O'Day K, Kanner SB. Engagement of the T lymphocyte antigen receptor regulates association of son-of-sevenless homologues with the SH3 domain of phospholipase Cgamma1. Eur J Immunol (2000) 30:2378-87. doi:10.1002/1521-4141(2000)30:8<2378::AID-IMMU2378>3.0.CO;2-E.
37. Halupa A, Chohan M, Stickle NH, Beattie BK, Miller BA, Barber DL. Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma. Exp Cell Res (2005) 309:1-11. doi:10.1016/j.yexcr.2005.04.030.
38. Wu C, Ma MH, Brown KR, Geisler M, Li L, Tzeng E, et al. Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening. Proteomics (2007) 7:1775-85. doi:10.1002/pmic.200601006.
39. Innocenti M, Tenca P, Frittoli E, Faretta M, Tocchetti A, Di Fiore PP, et al. Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol (2002) 156:125-36. doi:10.1083/jcb.200108035.
40. Rozakis-Adcock M, Van Der Geer P, Mbamalu G, Pawson T. MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes. Oncogene (1995) 11:1417-26.
41. Waters SB, Holt KH, Ross SE, Syu LJ, Guan KL, Saltiel AR, et al. Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J Biol Chem (1995) 270:20883-6. doi:10.1074/jbc.270.36.20883.
42. Corbalan-Garcia S, Degenhardt KR, Bar-Sagi D. Insulin-induced dissociation of Sos from Grb2 does not contribute to the down regulation of Ras activation. Oncogene (1996) 12:1063-8.
43. Corbalan-Garcia S, Yang SS, Degenhardt KR, Bar-Sagi D. Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol (1996) 16:5674-82.
44. Porfiri E, McCormick F. Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOS1. J Biol Chem (1996) 271:5871-7. doi:10.1074/jbc.271.10.5871.
45. Clyde-Smith J, Silins G, Gartside M, Grimmond S, Etheridge M, Apolloni A, et al. Characterization of RasGRP2, a plasma membrane-targeted, dual specificity Ras/Rap exchange factor. J Biol Chem (2000) 275:32260-7. doi:10.1074/jbc. M006087200.
46. Kawasaki H, Springett GM, Toki S, Canales JJ, Harlan P, Blumenstiel JP, et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci U S A (1998) 95:13278-83. doi:10.1073/pnas.95.22.13278.
47. Irie K, Masuda A, Shindo M, Nakagawa Y, Ohigashi H. Tumor promoter binding of the protein kinase C C1 homology domain peptides of RasGRPs, chimaerins, and Unc13s. Bioorg Med Chem (2004) 12:4575-83. doi:10.1016/j.bmc.2004.07.008.
48. Johnson JE, Goulding RE, Ding Z, Partovi A, Anthony KV, Beaulieu N, et al. Differential membrane binding and diacylglycerol recognition by C1 domains of RasGRPs. Biochem J (2007) 406:223-36. doi:10.1042/BJ20070294.
49. Grabarek Z. Structural basis for diversity of the EF-hand calcium-binding proteins. J Mol Biol (2006) 359:509-25. doi:10.1016/j.jmb.2006.03.066.
50. Gifford JL, Walsh MP, Vogel HJ. Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs. Biochem J (2007) 405:199-221. doi:10.1042/BJ20070255.
51. Ebinu JO, BottorffDA, Chan EY, Stang SL, Dunn RJ, Stone JC. RasGRP, a Ras guanyl nucleotide-releasing protein with calcium-and diacylglycerol-binding motifs. Science (1998) 280:1082-6. doi:10.1126/science.280.5366.1082.
52. Ksionda O, Limnander A, Roose JP. RasGRP proteins in cancer. Front Biol (2013) (in press).
53. Fernandez-Medarde A, Santos E. The RasGrf family of mammalian guanine nucleotide exchange factors. Biochim Biophys Acta (2011) 1815:170-88. doi:10.1016/j.bbcan.2010.11.001.
54. Cen H, Papageorge AG, Vass WC, Zhang KE, Lowy DR. Regulated and constitutive activity by CDC25Mm (GRF), a Ras-specific exchange factor. Mol Cell Biol (1993) 13:7718-24.
55. Lemmon MA, Ferguson KM. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J (2000) 350(Pt 1):1-18. doi:10.1042/0264-6021:3500001.
56. Parry DA, Fraser RD, Squire JM. Fifty years of coiled-coils and alpha-helical bundles: a close relationship between sequence and structure. J Struct Biol (2008) 163:258-69. doi:10.1016/j.jsb.2008.01.016.
57. Bahler M, Rhoads A. Calmodulin signaling via the IQ motif. FEBS Lett (2002) 513:107-13. doi:10.1016/S0014-5793(01)03239-2.
58. Buchsbaum RJ, Connolly BA, Feig LA. Interaction of Rac exchange factors Tiam1 and Ras-GRF1 with a scaffold for the p38 mitogen-activated protein kinase cascade. Mol Cell Biol (2002) 22:4073-85. doi:10.1128/MCB.22.12.4073-4085.2002.
59. Fan WT, Koch CA, De Hoog CL, Fam NP, Moran MF. The exchange factor Ras-GRF2 activates Ras-dependent and Rac-dependent mitogen-activated protein kinase pathways. Curr Biol (1998) 8:935-8. doi:10.1016/S0960-9822(07)00376-4.
60. Kiyono M, Satoh T, Kaziro Y. G protein beta gamma subunit-dependent Rac-guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm). Proc Natl Acad Sci U S A (1999) 96:4826-31. doi:10.1073/pnas.96.9.4826.
61. Priatel JJ, Teh SJ, Dower NA, Stone JC, Teh HS. RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation. Immunity (2002) 17:617-27. doi:10.1016/S1074-7613(02)00451-X.
62. Rambaratsingh RA, Stone JC, Blumberg PM, Lorenzo PS. RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes. J Biol Chem (2003) 278:52792-801. doi:10.1074/jbc. M308240200.
63. Zippel R, Gnesutta N, Matus-Leibovitch N, Mancinelli E, Saya D, Vogel Z, et al. Ras-GRF, the activator of Ras, is expressed preferentially in mature neurons of the central nervous system. Brain Res Mol Brain Res (1997) 48:140-4. doi:10.1016/S0169-328X(97)00120-4.
64. Ruiz S, Santos E, Bustelo XR. RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses. Mol Cell Biol (2007) 27:8127-42. doi:10.1128/MCB.00912-07.
65. Roose JP, Mollenauer M, Ho M, Kurosaki T, Weiss A. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol Cell Biol (2007) 27:2732-45. doi:10.1128/MCB.01882-06.
66. Das J, Ho M, Zikherman J, Govern C, Yang M, Weiss A, et al. Digital signaling and hysteresis characterize ras activation in lymphoid cells. Cell (2009) 136:337-51. doi:10.1016/j.cell.2008.11.051.
67. Kortum RL, Sommers CL, Pinski JM, Alexander CP, Merrill RK, Li W, et al. Deconstructing Ras signaling in the thymus. Mol Cell Biol (2012) 32:2748-59. doi:10.1128/MCB.00317-12.
68. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer (2007) 7:295-308. doi:10.1038/nrc2175.
69. Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet (2013) 381:333-42. doi:10.1016/S0140-6736(12)61023-X.
70. Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet (2007) 39:70-4. doi:10.1038/ng1926.
71. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet (2007) 39:75-9. doi:10.1038/ng0207-276a.
72. Zenker M, Horn D, Wieczorek D, Allanson J, Pauli S, Van Der Burgt I, et al. SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet (2007) 44:651-6. doi:10.1136/jmg.2007.051276.
73. Lepri F, De Luca A, Stella L, Rossi C, Baldassarre G, Pantaleoni F, et al. SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. Hum Mutat (2011) 32:760-72. doi:10.1002/humu.21492.
74. Chen PC, Wakimoto H, Conner D, Araki T, Yuan T, Roberts A, et al. Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome-associated Sos1 mutation. J Clin Invest (2010) 120:4353-65. doi:10.1172/JCI43910.
75. Yadav KK, Bar-Sagi D. Allosteric gating of Son of sevenless activity by the histone domain. Proc Natl Acad Sci U S A (2010) 107:3436-40. doi:10.1073/pnas.0914315107.
76. Oliveira JB, Bidere N, Niemela JE, Zheng L, Sakai K, Nix CP, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci U S A (2007) 104:8953-8. doi:10.1073/pnas.0702975104.
77. Niemela JE, Lu L, Fleisher TA, Davis J, Caminha I, Natter M, et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood (2011) 117:2883-6. doi:10.1182/blood-2010-07-295501.
78. Shannon K, Li Q. Oncogenic Ras scales the ALPS. Blood (2011) 117:2747-8. doi:10.1182/blood-2010-12-320721.
79. Takagi M, Shinoda K, Piao J, Mitsuiki N, Takagi M, Matsuda K, et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood (2011) 117:2887-90. doi:10.1182/blood-2010-08-301515.
80. Kane LP, Lin J, Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol (2000) 12:242-9. doi:10.1016/S0952-7915(00)00083-2.
81. Buday L, Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell (1993) 73:611-20. doi:10.1016/0092-8674(93)90146-H.
82. Buday L, Egan SE, Rodriguez Viciana P, Cantrell DA, Downward J. A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J Biol Chem (1994) 269:9019-23.
83. Aronheim A, Engelberg D, Li N, Al-Alawi N, Schlessinger J, Karin M. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell (1994) 78:949-61. doi:10.1016/0092-8674(94)90271-2.
84. McCollam L, Bonfini L, Karlovich CA, Conway BR, Kozma LM, Banerjee U, et al. Functional roles for the pleckstrin and Dbl homology regions in the Ras exchange factor Son-of-sevenless. J Biol Chem (1995) 270:15954-7. doi:10.1074/jbc.270.27.15954.
85. Wang W, Fisher EM, Jia Q, Dunn JM, Porfiri E, Downward J, et al. The Grb2 binding domain of mSos1 is not required for downstream signal transduction. Nat Genet (1995) 10:294-300. doi:10.1038/ng0795-294.
86. Corbalan-Garcia S, Margarit SM, Galron D, Yang SS, Bar-Sagi D. Regulation of Sos activity by intramolecular interactions. Mol Cell Biol (1998) 18:880-6.
87. Findlay GM, Smith MJ, Lanner F, Hsiung MS, Gish GD, Petsalaki E, et al. Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate. Cell (2013) 152:1008-20. doi:10.1016/j.cell.2013.01.056.
88. Gureasko J, Kuchment O, Makino DL, Sondermann H, Bar-Sagi D, Kuriyan J. Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless. Proc Natl Acad Sci U S A (2010) 107:3430-5. doi:10.1073/pnas.0913915107.
89. Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J. Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell (2004) 119:393-405. doi:10.1016/j.cell.2004.10.005.
90. Freedman TS, Sondermann H, Friedland GD, Kortemme T, Bar-Sagi D, Marqusee S, et al. A Ras-induced conformational switch in the Ras activator Son of sevenless. Proc Natl Acad Sci U S A (2006) 103:16692-7. doi:10.1073/pnas.0608127103.
91. Boykevisch S, Zhao C, Sondermann H, Philippidou P, Halegoua S, Kuriyan J, et al. Regulation of ras signaling dynamics by Sos-mediated positive feedback. Curr Biol (2006) 16:2173-9. doi:10.1016/j.cub.2006.09.033.
92. Jun JE, Li M, Chen H, Chakraborty AK, Roose JP. Activation of ERK but not of p38 MAP kinase pathways in lymphocytes requires allosteric activation of SOS. Mol Cell Biol (2013) 33:2470-84. doi:10.1128/MCB.01593-12.
93. Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, Groves JT, et al. Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat Struct Mol Biol (2008) 15:452-61. doi:10.1038/nsmb.1418.
94. Sondermann H, Nagar B, Bar-Sagi D, Kuriyan J. Computational docking and solution x-ray scattering predict a membrane-interacting role for the histone domain of the Ras activator son of sevenless. Proc Natl Acad Sci U S A (2005) 102:16632-7. doi:10.1073/pnas.0508315102.
95. Krishna S, Zhong X-P. Regulation of lipid signaling by diacylglycerol kinases during T cell development and function. Front Immunol (2013) 4:178. doi:10.3389/fimmu.2013.00178.
96. Sauer K, Cooke MP. Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate. Nat Rev Immunol (2010) 10:257-71. doi:10.1038/nri2745.
97. Aiba Y, Oh-Hora M, Kiyonaka S, Kimura Y, Hijikata A, Mori Y, et al. Activation of RasGRP3 by phosphorylation of Thr-133 is required for B cell receptor-mediated Ras activation. Proc Natl Acad Sci U S A (2004) 101:16612-7. doi:10.1073/pnas.0407468101.
98. Brodie C, Steinhart R, Kazimirsky G, Rubinfeld H, Hyman T, Ayres JN, et al. PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters. Mol Pharmacol (2004) 66:76-84. doi:10.1124/mol.66.1.76.
99. Coughlin JJ, Stang SL, Dower NA, Stone JC. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J Immunol (2005) 175:7179-84.
100. Roose JP, Mollenauer M, Gupta VA, Stone J, Weiss A. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol Cell Biol (2005) 25:4426-41. doi:10.1128/MCB.25.11.4426-4441.2005.
101. Limnander A, Depeille P, Freedman TS, Liou J, Leitges M, Kurosaki T, et al. STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol (2011) 12:425-33. doi:10.1038/ni.2016.
102. Qu HQ, Grant SF, Bradfield JP, Kim C, Frackelton E, Hakonarson H, et al. Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies. J Med Genet (2009) 46:553-4. doi:10.1136/jmg.2009.067140.
103. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet (2011) 7:e1002216. doi:10.1371/journal.pgen.1002216.
104. Yasuda S, Stevens RL, Terada T, Takeda M, Hashimoto T, Fukae J, et al. Defective expression of Ras guanyl nucleotide-releasing protein 1 in a subset of patients with systemic lupus erythematosus. J Immunol (2007) 179:4890-900.
105. Reuther GW, Lambert QT, Rebhun JF, Caligiuri MA, Quilliam LA, Der CJ. RasGRP4 is a novel Ras activator isolated from acute myeloid leukemia. J Biol Chem (2002) 277:30508-14. doi:10.1074/jbc. M111330200.
106. Yang D, Tao J, Li L, Kedei N, Toth ZE, Czap A, et al. RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Oncogene (2011) 30:4590-600. doi:10.1038/onc.2011.166.
107. Yang D, Kedei N, Li L, Tao J, Velasquez JF, Michalowski AM, et al. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype. Cancer Res (2010) 70:7905-17. doi:10.1158/0008-5472.CAN-09-4729.
108. Luke CT, Oki-Idouchi CE, Cline JM, Lorenzo PS. RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis. Cancer Res (2007) 67:10190-7. doi:10.1158/0008-5472.CAN-07-2375.
109. Oki-Idouchi CE, Lorenzo PS. Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin. Cancer Res (2007) 67:276-80. doi:10.1158/0008-5472.CAN-06-3080.
110. Diez FR, Garrido AA, Sharma A, Luke CT, Stone JC, Dower NA, et al. RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding. Potential role of granulocyte colony-stimulating factor. Am J Pathol (2009) 175:392-9. doi:10.2353/ajpath.2009.090036.
111. Klinger MB, Guilbault B, Goulding RE, Kay RJ. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors. Oncogene (2005) 24:2695-704. doi:10.1038/sj.onc.1208334.
112. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, Vink E, et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet (2002) 32:153-9. doi:10.1038/ng1002-331d.
113. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, et al. New genes involved in cancer identified by retroviral tagging. Nat Genet (2002) 32:166-74. doi:10.1038/ng1002-331e.
114. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res (2004) 32:D523-7. doi:10.1093/nar/gkh013.
115. Oki T, Kitaura J, Watanabe-Okochi N, Nishimura K, Maehara A, Uchida T, et al. Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis. Leukemia (2012) 26:1038-45. doi:10.1038/leu.2011.328.
116. Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, et al. Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis. Sci Signal (2013) 6:ra21. doi:10.1126/scisignal.2003848.
117. Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol (2007) 7:690-702. doi:10.1038/nri2152.
118. Zheng Y, Liu H, Coughlin J, Zheng J, Li L, Stone JC. Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and RAS signaling systems in B cells. Blood (2005) 105:3648-54. doi:10.1182/blood-2004-10-3916.
119. Fu G, Chen Y, Yu M, Podd A, Schuman J, He Y, et al. Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance. J Exp Med (2010) 207:309-18. doi:10.1084/jem.20090880.
120. Guo R, Wan CK, Carpenter JH, Mousallem T, Boustany RM, Kuan CT, et al. Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. Proc Natl Acad Sci U S A (2008) 105:11909-14. doi:10.1073/pnas.0711856105.
121. Olenchock BA, Guo R, Carpenter JH, Jordan M, Topham MK, Koretzky GA, et al. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol (2006) 7:1174-81. doi:10.1038/ni1400.
122. Zha Y, Marks R, Ho AW, Peterson AC, Janardhan S, Brown I, et al. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol (2006) 7:1166-73. doi:10.1038/ni1206-1343a.
123. Golec DP, Dower NA, Stone JC, Baldwin TA. RasGRP1, but not RasGRP3, is required for efficient thymic beta-selection and ERK activation downstream of CXCR4. PLoS One (2013) 8:e53300. doi:10.1371/journal.pone.0053300.
124. Kremer KN, Clift IC, Miamen AG, Bamidele AO, Qian NX, Humphreys TD, et al. Stromal cell-derived factor-1 signaling via the CXCR4-TCR heterodimer requires phospholipase C-beta3 and phospholipase C-gamma1 for distinct cellular responses. J Immunol (2011) 187:1440-7. doi:10.4049/jimmunol.1100820.
125. Limnander A, Weiss A. Ca-dependent Ras/Erk signaling mediates negative selection of autoreactive B cells. Small GTPases (2011) 2:282-8. doi:10.4161/sgtp.2.5.17794.
126. Fischer AM, Katayama CD, Pages G, Pouyssegur J, Hedrick SM. The role of erk1 and erk2 in multiple stages of T cell development. Immunity (2005) 23:431-43. doi:10.1016/j.immuni.2005.08.013.
127. Zhu M, Fuller DM, Zhang W. The role of Ras guanine nucleotide releasing protein 4 in Fc epsilonRI-mediated signaling, mast cell function, and T cell development. J Biol Chem (2012) 287:8135-43. doi:10.1074/jbc. M111.320580.
128. Poon HY, Stone JC. Functional links between diacylglycerol and phosphatidylinositol signaling systems in human leukocyte-derived cell lines. Biochem Biophys Res Commun (2009) 390:1395-401. doi:10.1016/j.bbrc.2009.11.004.
129. Beaulieu N, Zahedi B, Goulding RE, Tazmini G, Anthony KV, Omeis SL, et al. Regulation of RasGRP1 by B cell antigen receptor requires cooperativity between three domains controlling translocation to the plasma membrane. Mol Biol Cell (2007) 18:3156-68. doi:10.1091/mbc. E06-10-0932.
130. Zahedi B, Goo HJ, Beaulieu N, Tazmini G, Kay RJ, Cornell RB. Phosphoinositide 3-kinase regulates plasma membrane targeting of the Ras-specific exchange factor RasGRP1. J Biol Chem (2011) 286:12712-23. doi:10.1074/jbc. M110.189605.
131. Fuller DM, Zhu M, Song X, Ou-Yang CW, Sullivan SA, Stone JC, et al. Regulation of RasGRP1 function in T cell development and activation by its unique tail domain. PLoS One (2012) 7:e38796. doi:10.1371/journal.pone.0038796.
132. Tazmini G, Beaulieu N, Woo A, Zahedi B, Goulding RE, Kay RJ. Membrane localization of RasGRP1 is controlled by an EF-hand, and by the GEF domain. Biochim Biophys Acta (2009) 1793:447-61. doi:10.1016/j.bbamcr.2008.12.019.
133. Bivona TG, Perez De Castro I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ, et al. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature (2003) 424:694-8. doi:10.1038/nature01806.
134. Izquierdo M, Downward J, Graves JD, Cantrell DA. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells. Mol Cell Biol (1992) 12:3305-12.
135. Hille B. Ion Channels of Excitable Membranes. 3rd ed. Sunderland: Sinauer Associates, Inc (2001).
136. Topham MK, Prescott SM. Diacylglycerol kinase zeta regulates Ras activation by a novel mechanism. J Cell Biol (2001) 152:1135-43. doi:10.1083/jcb.152.6.1135.
137. Schneider H, Wang H, Raab M, Valk E, Smith X, Lovatt M, et al. Adaptor SKAP-55 binds p21 activating exchange factor RasGRP1 and negatively regulates the p21-ERK pathway in T-cells. PLoS One (2008) 3:e1718. doi:10.1371/journal.pone.0001718.
138. Kosco KA, Cerignoli F, Williams S, Abraham RT, Mustelin T. SKAP55 modulates T cell antigen receptor-induced activation of the Ras-Erk-AP1 pathway by binding RasGRP1. Mol Immunol (2008) 45:510-22. doi:10.1016/j.molimm.2007.05.024.
139. Oh-Hora M, Johmura S, Hashimoto A, Hikida M, Kurosaki T. Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase C-gamma2 to Ras in B cell receptor signaling. J Exp Med (2003) 198:1841-51. doi:10.1084/jem.20031547.
140. Warnecke N, Poltorak M, Kowtharapu BS, Arndt B, Stone JC, Schraven B, et al. TCR-mediated Erk activation does not depend on Sos and Grb2 in peripheral human T cells. EMBO Rep (2012) 13:386-91. doi:10.1038/embor.2012.17.
141. Tian T, Harding A, Inder K, Plowman S, Parton RG, Hancock JF. Plasma membrane nanoswitches generate high-fidelity Ras signal transduction. Nat Cell Biol (2007) 9:905-14. doi:10.1038/ncb1615.
142. Stefanova I, Hemmer B, Vergelli M, Martin R, Biddison WE, Germain RN. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat Immunol (2003) 4:248-54. doi:10.1038/ni895.
143. Bashor CJ, Helman NC, Yan S, Lim WA. Using engineered scaffold interactions to reshape MAP kinase pathway signaling dynamics. Science (2008) 319:1539-43. doi:10.1126/science.1151153.
144. Harding A, Tian T, Westbury E, Frische E, Hancock JF. Subcellular localization determines MAP kinase signal output. Curr Biol (2005) 15:869-73. doi:10.1016/j.cub.2005.04.020.
145. Prasad A, Zikherman J, Das J, Roose JP, Weiss A, Chakraborty AK. Origin of the sharp boundary that discriminates positive and negative selection of thymocytes. Proc Natl Acad Sci U S A (2009) 106:528-33. doi:10.1073/pnas.0805981105.
146. Werlen G, Hausmann B, Naeher D, Palmer E. Signaling life and death in the thymus: timing is everything. Science (2003) 299:1859-63. doi:10.1126/science.1067833.
147. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature (2006) 444:724-9. doi:10.1038/nature05269.
148. McGargill MA, Chen IL, Katayama CD, Pages G, Pouyssegur J, Hedrick SM. Cutting edge: extracellular signal-related kinase is not required for negative selection of developing T cells. J Immunol (2009) 183:4838-42. doi:10.4049/jimmunol.0902208.
149. Kortum RL, Rouquette-Jazdanian AK, Samelson LE. Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells. Trends Immunol (2013) 34:259-68. doi:10.1016/j.it.2013.02.004.
150. Rubio I, Rennert K, Wittig U, Beer K, Durst M, Stang SL, et al. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells. Biochem J (2006) 398:243-56. doi:10.1042/BJ20060160.
151. Markegard E, Trager E, Yang CW, Zhang W, Weiss A, Roose JP. Basal LAT-diacylglycerol-RasGRP1 signals in T cells maintain TCRalpha gene expression. PLoS One (2011) 6:e25540. doi:10.1371/journal.pone.0025540.
152. Sugawara T, Moriguchi T, Nishida E, Takahama Y. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity (1998) 9:565-74. doi:10.1016/S1074-7613(00)80639-1.
153. Gong Q, Cheng AM, Akk AM, Alberola-Ila J, Gong G, Pawson T, et al. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat Immunol (2001) 2:29-36. doi:10.1038/83134.
154. Jang IK, Zhang J, Chiang YJ, Kole HK, Cronshaw DG, Zou Y, et al. Grb2 functions at the top of the T-cell antigen receptor-induced tyrosine kinase cascade to control thymic selection. Proc Natl Acad Sci U S A (2010) 107:10620-5. doi:10.1073/pnas.0905039107.
155. Willingham MC, Pastan I, Shih TY, Scolnick EM. Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell (1980) 19:1005-14. doi:10.1016/0092-8674(80)90091-4.
156. Furth ME, Davis LJ, Fleurdelys B, Scolnick EM. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol (1982) 43:294-304.
157. Myrdal SE, Auersperg N. p21ras. Heterogeneous localization in transformed cells. Exp Cell Res (1985) 159:441-50. doi:10.1016/S0014-4827(85)80017-3.
158. Grand RJ, Smith KJ, Gallimore PH. Purification and characterisation of the protein encoded by the activated human N-ras gene and its membrane localisation. Oncogene (1987) 1:305-14.
159. Matarazzo M, Faraggiana T, Donato MF, Paronetto F. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice. J Exp Pathol (1987) 3:305-15.
160. Cox AD, Solski PA, Jordan JD, Der CJ. Analysis of Ras protein expression in mammalian cells. Methods Enzymol (1995) 255:195-220. doi:10.1016/S0076-6879(95)55023-2.
161. Kranenburg O, Verlaan I, Moolenaar WH. Regulating c-Ras function. cholesterol depletion affects caveolin association. Curr Biol (2001) 11:1880-4. doi:10.1016/S0960-9822(01)00582-6.
162. Rubio I. Use of the Ras binding domain of c-Raf for biochemical and live-cell analysis of Ras activation. Biochem Soc Trans (2005) 33:662-3. doi:10.1042/BST0330662.
163. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D, et al. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell (1999) 98:69-80. doi:10.1016/S0092-8674(00)80607-8.
164. Rocks O, Peyker A, Bastiaens PI. Spatio-temporal segregation of Ras signals: one ship, three anchors, many harbors. Curr Opin Cell Biol (2006) 18:351-7. doi:10.1016/j.ceb.2006.06.007.
165. Prior IA, Hancock JF. Ras trafficking, localization and compartmentalized signalling. Semin Cell Dev Biol (2012) 23:145-53. doi:10.1016/j.semcdb.2011.09.002.
166. Goodwin JS, Drake KR, Rogers C, Wright L, Lippincott-Schwartz J, Philips MR, et al. Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. J Cell Biol (2005) 170:261-72. doi:10.1083/jcb.200502063.
167. Dekker FJ, Rocks O, Vartak N, Menninger S, Hedberg C, Balamurugan R, et al. Small-molecule inhibition of APT1 affects Ras localization and signaling. Nat Chem Biol (2010) 6:449-56. doi:10.1038/nchembio.362.
168. Lorentzen A, Kinkhabwala A, Rocks O, Vartak N, Bastiaens PI. Regulation of Ras localization by acylation enables a mode of intracellular signal propagation. Sci Signal (2010) 3:ra68. doi:10.1126/scisignal.20001370.
169. Rocks O, Gerauer M, Vartak N, Koch S, Huang ZP, Pechlivanis M, et al. The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins. Cell (2010) 141:458-71. doi:10.1016/j.cell.2010.04.007.
170. Duncan JA, Gilman AG. A cytoplasmic acyl-protein thioesterase that removes palmitate from G protein alpha subunits and p21(RAS). J Biol Chem (1998) 273:15830-7. doi:10.1074/jbc.273.25.15830.
171. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, et al. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell (2006) 21:481-93. doi:10.1016/j.molcel.2006.01.012.
172. Lu A, Tebar F, Alvarez-Moya B, Lopez-Alcala C, Calvo M, Enrich C, et al. A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes. J Cell Biol (2009) 184:863-79. doi:10.1083/jcb.200807186.
173. Perez de Castro I, Bivona TG, Philips MR, Pellicer A. Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol Cell Biol (2004) 24:3485-96. doi:10.1128/MCB.24.8.3485-3496.2004.
174. Mor A, Campi G, Du G, Zheng Y, Foster DA, Dustin ML, et al. The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat Cell Biol (2007) 9:713-9. doi:10.1038/ncb1592.
175. Bivona TG, Quatela S, Philips MR. Analysis of Ras activation in living cells with GFP-RBD. Methods Enzymol (2006) 407:128-43. doi:10.1016/S0076-6879(05)07012-6.
176. Quatela SE, Philips MR. Ras signaling on the Golgi. Curr Opin Cell Biol (2006) 18:162-7. doi:10.1016/j.ceb.2006.02.004.
177. Rubio I, Grund S, Song SP, Biskup C, Bandemer S, Fricke M, et al. TCR-induced activation of Ras proceeds at the plasma membrane and requires palmitoylation of N-Ras. J Immunol (2010) 185:3536-43. doi:10.4049/jimmunol.1000334.
178. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, et al. Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol (2002) 4:343-50.
179. Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M, et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science (2005) 307:1746-52. doi:10.1126/science.1105654.
180. Baldanzi G, Pighini A, Bettio V, Rainero E, Traini S, Chianale F, et al. SAP-mediated inhibition of diacylglycerol kinase alpha regulates TCR-induced diacylglycerol signaling. J Immunol (2011) 187:5941-51. doi:10.4049/jimmunol.1002476.
181. Arndt B, Poltorak M, Kowtharapu BS, Reichardt P, Philipsen L, Lindquist JA, et al. Analysis of TCR activation kinetics in primary human T cells upon focal or soluble stimulation. J Immunol Methods (2013) 387:276-83. doi:10.1016/j.jim.2012.11.006.
182. Bankaitis VA. Cell biology. Slick recruitment to the Golgi. Science (2002) 295:290-1. doi:10.1126/science.1068446.
183. Augsten M, Pusch R, Biskup C, Rennert K, Wittig U, Beyer K, et al. Live-cell imaging of endogenous Ras-GTP illustrates predominant Ras activation at the plasma membrane. EMBO Rep (2006) 7:46-51. doi:10.1038/sj.embor.7400560.
184. Methi T, Ngai J, Vang T, Torgersen KM, Tasken K. Hypophosphorylated TCR/CD3zeta signals through a Grb2-SOS1-Ras pathway in Lck knockdown cells. Eur J Immunol (2007) 37:2539-48. doi:10.1002/eji.200636973.
185. Baron CL, Malhotra V. Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane. Science (2002) 295:325-8. doi:10.1126/science.1066759.
186. Jones DR, D'Santos CS, Merida I, Divecha N. T lymphocyte nuclear diacylglycerol is derived from both de novo synthesis and phosphoinositide hydrolysis. Int J Biochem Cell Biol (2002) 34:158-68. doi:10.1016/S1357-2725(01)00108-X.
187. Carrasco S, Merida I. Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci (2007) 32:27-36. doi:10.1016/j.tibs.2006.11.004.
188. Almena M, Merida I. Shaping up the membrane: diacylglycerol coordinates spatial orientation of signaling. Trends Biochem Sci (2011) 36:593-603. doi:10.1016/j.tibs.2011.06.005.
189. Oancea E, Teruel MN, Quest AF, Meyer T. Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells. J Cell Biol (1998) 140:485-98. doi:10.1083/jcb.140.3.485.
190. Carrasco S, Merida I. Diacylglycerol-dependent binding recruits PKCtheta and RasGRP1 C1 domains to specific subcellular localizations in living T lymphocytes. Mol Biol Cell (2004) 15:2932-42. doi:10.1091/mbc. E03-11-0844.
191. Spitaler M, Emslie E, Wood CD, Cantrell D. Diacylglycerol and protein kinase D localization during T lymphocyte activation. Immunity (2006) 24:535-46. doi:10.1016/j.immuni.2006.02.013.
192. Merino E, Sanjuan MA, Moraga I, Cipres A, Merida I. Role of the diacylglycerol kinase alpha-conserved domains in membrane targeting in intact T cells. J Biol Chem (2007) 282:35396-404. doi:10.1074/jbc. M702085200.
193. Espagnolle N, Depoil D, Zaru R, Demeur C, Champagne E, Guiraud M, et al. CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse. Int Immunol (2007) 19:239-48. doi:10.1093/intimm/dxl141.
194. Caloca MJ, Delgado P, Alarcon B, Bustelo XR. Role of chimaerins, a group of Rac-specific GTPase activating proteins, in T-cell receptor signaling. Cell Signal (2008) 20:758-70. doi:10.1016/j.cellsig.2007.12.015.
195. Gharbi SI, Rincon E, Avila-Flores A, Torres-Ayuso P, Almena M, Cobos MA, et al. Diacylglycerol kinase zeta controls diacylglycerol metabolism at the immunological synapse. Mol Biol Cell (2011) 22:4406-14. doi:10.1091/mbc. E11-03-0247.
196. Quann EJ, Merino E, Furuta T, Huse M. Localized diacylglycerol drives the polarization of the microtubule-organizing center in T cells. Nat Immunol (2009) 10:627-35. doi:10.1038/ni.1734.
197. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature (1998) 395:82-6. doi:10.1038/25764.
198. Villalba M, Bi K, Hu J, Altman Y, Bushway P, Reits E, et al. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K-and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol (2002) 157:253-63. doi:10.1083/jcb.200201097.
199. Zugaza JL, Caloca MJ, Bustelo XR. Inverted signaling hierarchy between RAS and RAC in T-lymphocytes. Oncogene (2004) 23:5823-33. doi:10.1038/sj.onc.1207768.
200. Phee H, Abraham RT, Weiss A. Dynamic recruitment of PAK1 to the immunological synapse is mediated by PIX independently of SLP-76 and Vav1. Nat Immunol (2005) 6:608-17. doi:10.1038/ni1199.
201. Wennstrom S, Downward J. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol Cell Biol (1999) 19:4279-88.
202. Rubio I, Wetzker R. A permissive function of phosphoinositide 3-kinase in Ras activation mediated by inhibition of GTPase-activating proteins. Curr Biol (2000) 10:1225-8. doi:10.1016/S0960-9822(00)00731-4.
203. Costello PS, Gallagher M, Cantrell DA. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat Immunol (2002) 3:1082-9. doi:10.1038/ni848.
204. Harriague J, Bismuth G. Imaging antigen-induced PI3K activation in T cells. Nat Immunol (2002) 3:1090-6. doi:10.1038/ni847.
205. Garcon L, Lacout C, Svinartchouk F, Le Couedic JP, Villeval JL, Vainchenker W, et al. Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood (2005) 105:1448-55. doi:10.1182/blood-2003-11-4068.
206. Randriamampita C, Mouchacca P, Malissen B, Marguet D, Trautmann A, Lellouch AC. A novel ZAP-70 dependent FRET based biosensor reveals kinase activity at both the immunological synapse and the antisynapse. PLoS One (2008) 3:e1521. doi:10.1371/journal.pone.0001521.
207. Sperka T, Geissler KJ, Merkel U, Scholl I, Rubio I, Herrlich P, et al. Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. PLoS One (2011) 6:e27511. doi:10.1371/journal.pone.0027511.
208. Martinelli S, Chen EJ, Clarke F, Lyck R, Affentranger S, Burkhardt JK, et al. Ezrin/Radixin/Moesin proteins and flotillins cooperate to promote uropod formation in T cells. Front Immunol (2013) 4:84. doi:10.3389/fimmu.2013.00084.
209. Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol (2012) 13:195-203. doi:10.1038/nrm3290.
210. Suire S, Condliffe AM, Ferguson GJ, Ellson CD, Guillou H, Davidson K, et al. Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. Nat Cell Biol (2006) 8:1303-9. doi:10.1038/ncb1494.
211. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, et al. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell (2007) 129:957-68. doi:10.1016/j.cell.2007.03.051.
212. Castellano E, Downward J. RAS interaction with PI3K: more than just another effector pathway. Genes Cancer (2011) 2:261-74. doi:10.1177/1947601911408079.
213. Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science (1995) 268:100-2. doi:10.1126/science.7701328.
214. Lockyer PJ, Wennstrom S, Kupzig S, Venkateswarlu K, Downward J, Cullen PJ. Identification of the ras GTPase-activating protein GAP1(m) as a phosphatidylinositol-3,4,5-trisphosphate-binding protein in vivo. Curr Biol (1999) 9:265-8. doi:10.1016/S0960-9822(99)80116-X.
215. Tomlinson MG, Kane LP, Su J, Kadlecek TA, Mollenauer MN, Weiss A. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec. Mol Cell Biol (2004) 24:2455-66. doi:10.1128/MCB.24.6.2455-2466.2004.
216. Qin S, Stadtman ER, Chock PB. Regulation of oxidative stress-induced calcium release by phosphatidylinositol 3-kinase and Bruton's tyrosine kinase in B cells. Proc Natl Acad Sci U S A (2000) 97:7118-23. doi:10.1073/pnas.130198197.
217. Varnai P, Bondeva T, Tamas P, Toth B, Buday L, Hunyady L, et al. Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell Sci (2005) 118:4879-88. doi:10.1242/jcs.02606.
218. Mohamed AJ, Yu L, Backesjo CM, Vargas L, Faryal R, Aints A, et al. Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. Immunol Rev (2009) 228:58-73. doi:10.1111/j.1600-065X.2008.00741.x.
219. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med (1996) 184:31-40. doi:10.1084/jem.184.1.31.
220. Saito K, Tolias KF, Saci A, Koon HB, Humphries LA, Scharenberg A, et al. BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity (2003) 19:669-78. doi:10.1016/S1074-7613(03)00297-8.
221. Schaeffer EM, Schwartzberg PL. Tec family kinases in lymphocyte signaling and function. Curr Opin Immunol (2000) 12:282-8. doi:10.1016/S0952-7915(00)00088-1.
222. Gomez-Rodriguez J, Kraus ZJ, Schwartzberg PL. Tec family kinases Itk and Rlk/Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates. FEBS J (2011) 278:1980-9. doi:10.1111/j.1742-4658.2011.08072.x.
223. Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe H, et al. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell (1999) 99:521-32. doi:10.1016/S0092-8674(00)81540-8.
224. Stephens L, Eguinoa A, Corey S, Jackson T, Hawkins PT. Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J (1993) 12:2265-73.
225. Stephens L, Jackson T, Hawkins PT. Synthesis of phosphatidylinositol 3,4,5-trisphosphate in permeabilized neutrophils regulated by receptors and G-proteins. J Biol Chem (1993) 268:17162-72.
226. Hallberg B, Rayter SI, Downward J. Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J Biol Chem (1994) 269:3913-6.
227. Ghosh S, Bell RM. Regulation of Raf-1 kinase by interaction with the lipid second messenger, phosphatidic acid. Biochem Soc Trans (1997) 25:561-5.
228. Rizzo MA, Shome K, Watkins SC, Romero G. The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J Biol Chem (2000) 275:23911-8. doi:10.1074/jbc. M001553200.
229. Mollinedo F, Gajate C, Flores I. Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid Jurkat cells. J Immunol (1994) 153:2457-69.
230. Reid PA, Gardner SD, Williams DM, Harnett MM. The antigen receptors on mature and immature T lymphocytes are coupled to phosphatidylcholine-specific phospholipase D activation. Immunology (1997) 90:250-6. doi:10.1046/j.1365-2567.1997.00150.x.
231. Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Medarde A, Swaminathan N, Yienger K, et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol (2001) 21:1444-52. doi:10.1128/MCB.21.5.1444-1452.2001.
232. Iborra S, Soto M, Stark-Aroeira L, Castellano E, Alarcon B, Alonso C, et al. H-ras and N-ras are dispensable for T-cell development and activation but critical for protective Th1 immunity. Blood (2011) 117:5102-11. doi:10.1182/blood-2010-10-315770.
233. Simon JA, Schreiber SL. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions. Chem Biol (1995) 2:53-60. doi:10.1016/1074-5521(95)90080-2.
234. Houtman JC, Yamaguchi H, Barda-Saad M, Braiman A, Bowden B, Appella E, et al. Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1. Nat Struct Mol Biol (2006) 13:798-805. doi:10.1038/nsmb1133.
235. Nag A, Monine MI, Faeder JR, Goldstein B. Aggregation of membrane proteins by cytosolic cross-linkers: theory and simulation of the LAT-Grb2-SOS1 system. Biophys J (2009) 96:2604-23. doi:10.1016/j.bpj.2009.01.019.
236. Sherman E, Barr V, Manley S, Patterson G, Balagopalan L, Akpan I, et al. Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. Immunity (2011) 35:705-20. doi:10.1016/j.immuni.2011.10.004.
237. Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, Samelson LE. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling. J Biol Chem (2000) 275:23355-61. doi:10.1074/jbc. M000404200.
238. Lin J, Weiss A. Identification of the minimal tyrosine residues required for linker for activation of T cell function. J Biol Chem (2001) 276:29588-95. doi:10.1074/jbc. M102221200.
239. Braga VM. GEF without a Dbl domain? Nat Cell Biol (2002) 4:E188-90. doi:10.1038/ncb0802-e188.
240. Nimnual A, Bar-Sagi D. The two hats of SOS. Sci STKE (2002) 2002:E36. doi:10.1126/stke.2002.145.pe36.
241. Hashimoto A, Okada H, Jiang A, Kurosaki M, Greenberg S, Clark EA, et al. Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med (1998) 188:1287-95. doi:10.1084/jem.188.7.1287.
242. Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol (2006) 6:532-40. doi:10.1038/nri1865.